All In MedTech

Device Trial Radar · NCT03299959

Agili-C™ Implant Performance Evaluation

A Prospective Multicenter Open-label Randomized Controlled Trial of Agili-C™ vs. Surgical Standard of Care (SSOC) for the Treatment of Joint Surface Lesions of the Knee

Last checked: Nov 20, 2026Latest source record: Dec 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 251 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

251

Actual

Start

Sep 25, 2017

Primary completion

Nov 14, 2024

Study completion Nov 14, 2024

Sponsor

Lead sponsor
Smith & Nephew, Inc.Public (SNN)
Sponsor type
Industry
First posted
Oct 3, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 21 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The current study compares the efficacy and safety of the Agili-C implant to Surgical Standard of Care treatment in patients suffering from joint surface lesions of the knee. The patient population is heterogeneous, involving different kinds of joint surface lesions: focal cartilage lesions, osteochondral defects and mild to moderate osteoarthritis, including multiple defects.

Conditions

  • Cartilage or Osteochondral Defects in the Knee
  • Up to Moderate Osteoarthritis

Interventions

  • Agili-C implantDevice

    Agili-C implant

  • SSOCProcedure

    microfracture and/or debridement

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Knee Injury and Osteoarthritis Outcome Score (KOOS) Change From Baseline to 60 MonthsTime frame: Baseline, 60 Months

Locations

26 sites in 8 countries. Site status is shown where the registry gives one.

  • Horizon Clinical Research

    San Diego, California

25 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.